Corrigendum to ‘Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States’: [ESMO Open Volume 6, Issue 5, October 2021, 100252] (ESMO Open (2021) 6(5), (S2059702921002131), (10.1016/j.esmoop.2021.100252))

The authors regret that at the time the article was published there were some minor errors which have now been corrected. In the introduction the sentence “ICIs act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” has been corrected to “Immune checkpoints act as negative regulators of autoreactive T cells, resulting in immune tolerance and prevention of autoimmunity.” In Figure 2 a label was corrected to irAE as per the below. The authors would like to apologise for any inconvenience caused.